Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study

PURPOSE: Pseudo-progression (PsPD) is a rare phenomenon observed in <5% of cases of non-small cell lung cancer (NSCLC). This event is challenging for both clinicians and patients. Viable biomarkers to distinguish between PsPD and true progressive disease (TPD) are lacking. The aim of our study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiriu, Tatsunori, Yamamoto, Masatsugu, Nagano, Tatsuya, Hazama, Daisuke, Sekiya, Reina, Katsurada, Masahiro, Katsurada, Naoko, Tachihara, Motoko, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897378/
https://www.ncbi.nlm.nih.gov/pubmed/31819535
http://dx.doi.org/10.2147/OTT.S228138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897378/
https://www.ncbi.nlm.nih.gov/pubmed/31819535
http://dx.doi.org/10.2147/OTT.S228138

Ejemplares similares